Providing patients with pharmacogenetic test results affects adherence to statin therapy: results of the Additional KIF6 Risk Offers Better Adherence to Statins (AKROBATS) trial by Charland S L, Agatep B C, Herrera V, Schrader B, Frueh F W, Ryvkin M, Shabbeer J, Devlin J J, Superko H R, Stanek E J in The pharmacogenomics journal (2013).

[PMID: 23979174] PubMed


Discussed In Paper


Rx Annotations

No dosing information annotated.